: Identified by Morningstar as an undervalued mega-cap to buy before price "discounts" disappear.

Beyond broad tech, analysts have highlighted specific leaders in healthcare and finance.

: Highlighted as a top growth pick on Zacks and U.S. News, fueled by a 70% revenue increase in data analytics and AI software.